Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-31

FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for citalopram hydrobromide by Aurobindo Pharma Limited, representing a generic version of citalopram. This action is an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM HYDROBROMIDE)